Skip to main content
. 2024 Sep 26;2024(9):CD006689. doi: 10.1002/14651858.CD006689.pub3

2.12. Analysis.

2.12

Comparison 2: Mefloquine (MQ) plus daily cotrimoxazole (CTXp) versus CTXp, Outcome 12: Severe adverse events during pregnancy